Selames 240 mg spot-on solution for dogs 20.1–40.0 kg
Selames 240 mg spot-on solution for dogs 20.1–40.0 kg
Authorised
- Selamectin
Product identification
Medicine name:
Selames 240 mg spot-on solution for dogs 20.1–40.0 kg
Selames voor honden 20,1-40,0 kg 240 mg Spot-on oplossing
Selames pour chiens 20,1-40,0 kg 240 mg Solution pour spot-on
Selames fur Hunde 20,1-40,0 kg 240 mg Lösung zum Auftropfen
Active substance:
- Selamectin
Target species:
-
Dog
Route of administration:
-
Spot-on use
Product details
Active substance and strength:
-
Selamectin240.00/milligram(s)1.00Pipette
Pharmaceutical form:
-
Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AA05
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Translucent polypropylene unit-dose pipette with polyethylene or polyoxymethylene or polypropylene closure with spikepackaged into a laminated triplex bag composed of polyester, aluminium and polyethylene.Cardboard box containing 1 pipette.
- Translucent polypropylene unit-dose pipette with polyethylene or polyoxymethylene or polypropylene closure with spikepackaged into a laminated triplex bag composed of polyester, aluminium and polyethylene.Cardboard box containing 3 pipettes.
- Translucent polypropylene unit-dose pipette with polyethylene or polyoxymethylene or polypropylene closure with spikepackaged into a laminated triplex bag composed of polyester, aluminium and polyethylene.Cardboard box containing 6 pipettes.
- Translucent polypropylene unit-dose pipette with polyethylene or polyoxymethylene or polypropylene closure with spikepackaged into a laminated triplex bag composed of polyester, aluminium and polyethylene.Cardboard box containing 15 pipettes.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- TAD Pharma GmbH
- KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V537093
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0407/004
Concerned member states:
-
Belgium
-
France
-
Germany
-
Italy
-
Netherlands
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
